Hassan, S.Davies, J.Smith, M.Tsitsikas, D.Oakervee, H.Hallam, S.Taussig, D.Gribben, J.Cavenagh, J.
(2015). DURABLE REMISSIONS AFTER SEQUENTIAL TRANSPLANTATION USING T-REPLETE NON-MYELOABLATIVE CONDITIONING FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASIA,
HAEMATOLOGICA,
Vol.100,
p.278.
Hassan, S.Matthews, J.Guy, A.Farrell, M.Taussig, D.Smith, M.Oakervee, H.Cavenagh, J.Gribben, J.
(2014). REDUCED INTENSITY ALLOGENEIC TRANSPLANTATION IN MULTIPLE MYELOMA,
BONE MARROW TRANSPLANTATION,
Vol.49,
pp.S350-S351.
Manodoro, F.Marzec, J.Chaplin, T.Miraki-Moud, F.Moravcsik, E.Jovanovic, J.V.Wang, J.Iqbal, S.Taussig, D.Grimwade, D.Gribben, J.G.Young, B.D.Debernardi, S.
(2014). Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukaemia,
BRITISH JOURNAL OF HAEMATOLOGY,
Vol.165,
p.16.
Ghazaly, E.Smith, P.Gnanaranjan, C.Young, B.D.Joel, S.Gribben, J.G.Taussig, D.C.
(2014). SKIP Is Underexpressed in AML Leading to Sphingosine Kinase Hypofunction,
BLOOD,
Vol.124
(21).
Miraki-Moud, F.Ariza-McNaughton, L.Ghazaly, E.A.Hodby, K.A.Luong, P.Clear, A.Sohrabi, F.Bomalaski, J.Gribben, J.Bonnet, D.Szlosarek, P.Taussig, D.C.
(2013). Arginine Deprivation With Pegylated Arginine Deiminase Induces Death Of Acute Myeloid Leukaemia Cells In Vivo,
Blood,
Vol.122
(21),
p.1458.
Jasani, P.D.MacDougall, F.Smith, M.L.Cavenagh, J.D.Lister, T.A.Gribben, J.G.Taussig, D.C.Oakervee, H.E.
(2012). Treatment of acute myeloid leukaemia in the elderly: a retrospective analysis,
BRITISH JOURNAL OF HAEMATOLOGY,
Vol.157,
pp.64-65.
Iyengar, S.Ariza-McNaughton, L.Clear, A.J.Roe, A.Lillington, D.Taussig, D.C.Gribben, J.G.Joel, S.Bonnet, D.
(2012). Human Primary Mantle Cell Lymphoma Can Be Established in NOD/SCID/IL2Rγ-Null Mice,
Blood,
Vol.120
(21),
p.1565.
Butler, T.Montoya, A.Clear, A.J.Coutinho, R.Taussig, D.C.Cutillas, P.Gribben, J.G.
(2012). Anergic Response to B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia: The Differing Roles of IgD and IgM in the Microenvironment and Peripheral Blood.,
Blood,
Vol.120
(21),
p.2889.
Butler, T.Taussig, D.Cutillas, P.Gribben, J.
(2012). PHOSPHOPROTEOMIC ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND B-CELL RECEPTOR SIGNALING SUGGESTS NOVEL THERAPEUTIC TARGETS,
HAEMATOLOGICA,
Vol.97,
p.49.
Greaves, P.Iqbal, S.Rosignoli, G.Matthews, J.Wilson, A.Taussig, D.Gribben, J.
(2012). DOMINANCE OF NAIVE AND CENTRAL MEMORY CD4+T CELLS IN THE CLASSICAL HODGKIN LYMPHOMA MICROENVIRONMENT PROVIDES A DISTINCTIVE SIGNATURE WITH IMPLICATIONS FOR PATHOGENESIS AND CLINICAL DIAGNOSIS,
HAEMATOLOGICA,
Vol.97,
p.81.
Szlosarek, P.W.Luong, F.Clear, A.Taussig, D.Joel, S.Calaminici, M.Debernardi, S.Fitzgibbon, J.Bomalaski, J.S.Frankel, A.E.Bonnet, D.
(2011). Abstract 4067: Pegylated arginine deiminase (ADI-PEG20) as a potential novel therapy for argininosuccinate synthetase-deficient acute myeloid leukemia,
Presented at Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL, Cellular and Molecular Biology, .
Taussig, D.C.Gribben, J.G.
(2011). Continuous CD4+ T Cell Lines Derived From the Classical Hodgkin Lymphoma Microenvironment: A Challenge to the Assumption of Anergy,
BLOOD,
Vol.118
(21),
pp.1556-1557.
Mannari, D.Jasani, P.MacDougall, F.Taussig, D.Cavenagh, J.
(2010). ALLOGENEIC HAEMOPOIETIC STEM-CELL TRANSPLANTATION USING A NON T-CELL DEPLETE REDUCED INTENSITY CONDITIONING PROTOCOL FOR ACUTE MYELOID LEUKAEMIA & MYELODYSPLASIA: A 10-YEAR SINGLE CENTRE EXPERIENCE,
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL,
Vol.95,
p.275.
Ghazaly, E.Smith, P.Quentmeier, H.Drexler, H.Iqbal, S.Taussig, D.Young, B.Lister, A.Joel, S.Fitzgibbon, J.
(2010). ACCUMULATION OF 2-HYDROXYGLUTARATE (2-HG) IN NORMAL KARYOTYPE AML PATIENTS WITH IDH1 MUTATION,
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL,
Vol.95,
p.20.
Taussig, D.Miraki-Moud, F.Lister, A.Bonnet, D.Gribben, J.
(2010). BONE MARROW FAILURE IN ACUTE MYELOID LEUKEMIA IS INDUCED BY A BLOCK IN DIFFERENTIATION OF NORMAL HEMATOPOIETIC STEM CELLS,
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL,
Vol.95,
p.13.
Taussig, D.Miraki-Moud, F.Lister, A.Bonnet, D.Gribben, J.
(2010). BONE MARROW FAILURE IN ACUTE MYELOID LEUKEMIA IS INDUCED BY A BLOCK IN DIFFERENTIATION OF NORMAL HEMATOPOIETIC STEM CELLS,
HAEMATOLOGICA,
Vol.95,
p.13.
Mannari, D.Jasani, P.Macdougall, F.Taussig, D.Cavenagh, J.
(2010). ALLOGENEIC HAEMOPOIETIC STEM-CELL TRANSPLANTATION USING A NON T-CELL DEPLETE REDUCED INTENSITY CONDITIONING PROTOCOL FOR ACUTE MYELOID LEUKAEMIA & MYELODYSPLASIA: A 10-YEAR SINGLE CENTRE EXPERIENCE,
HAEMATOLOGICA,
Vol.95,
p.275.
Ghazaly, E.Smith, P.Quentmeier, H.Drexler, H.Iqbal, S.Taussig, D.Young, B.Lister, A.Joel, S.Fitzgibbon, J.
(2010). ACCUMULATION OF 2-HYDROXYGLUTARATE (2-HG) IN NORMAL KARYOTYPE AML PATIENTS WITH IDH1 MUTATION,
HAEMATOLOGICA,
Vol.95,
p.20.
Tsitsikas, D.A.Warcel-Sibony, D.Oakervee, H.E.Agrawal, S.G.Smith, M.Taussig, D.C.de Vos, J.Stewart, E.Nicholas, H.Gribben, J.G.Cavenagh, J.D.
(2010). A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukaemia, High-Risk MDS and Other High Risk Myeoid Malignancies: An Interim Report,
BLOOD,
Vol.116
(21),
p.1430.
Le Dieu, R.Taussig, D.MacDougal, F.Lister, A.Gribben, J.G.
(2007). CD3+/CD56+cells, but not natural killer T cells, are increased in peripheral blood of untreated patients with leukemia,
BLOOD,
Vol.110
(11),
p.538A.
Pearce, D.J.Taussig, D.Eddaoudi, A.Bonnet, D.
(2005). Age-dependent changes in hematopoietic stem and progenitor cells,
EXPERIMENTAL HEMATOLOGY,
Vol.33
(7),
p.90.
Zibara, K.Pearce, D.Taussig, D.Bureau, E.Skoulakis, S.Tomlinson, S.Young, B.
(2005). Gene expression profiling reveals fundamental differences between leukemic stem cells (Lin-CD34+CD38-) and mature blasts (Lin-CD34+CD38+) of acute myeloid leukaemia (AML) patients,
EXPERIMENTAL HEMATOLOGY,
Vol.33
(7),
p.83.
Zibara, K.Pearce, D.Taussig, D.Skoulakis, S.Tomlinson, S.Bureau, E.Young, B.D.Bonnet, D.
(2005). Gene expression profiling reveals fundamental differences between leukemic stem cells (Lin-CD34+CD38-) and mature blasts (Lin-CD34+CD38+) of acute myeloid leukaemia (AML) patients.,
BLOOD,
Vol.106
(11),
p.399A.
Pearce, D.J.Taussig, D.Simpson, C.Bonnet, D.
(2004). A high ALDH activity identifies both normal and leukemic stem cells,
BLOOD,
Vol.104
(11),
p.199B.
Taussig, D.Pearce, D.J.Simpson, C.Rohatiner, A.Lister, T.A.Bonnet, D.
(2003). Acute myeloid leukaemia stem cells express the CD33 antigen.,
BLOOD,
Vol.102
(11),
p.143B.
Oakervee, H.E.Gordon, A.C.Kaya, B.Taussig, D.C.Lockley, M.Barnett, M.J.Rohatiner, A.Z.Lister, T.A.Hinds, C.J.Cavenagh, J.D.
(2002). Outcomes of critical illness in patients with haematological malignancy.,
BLOOD,
Vol.100
(11),
pp.875A-876A.
Taussig, D.C.Cavenagh, J.D.Davies, A.J.Oakervee, H.Syndercombe-Court, D.Kelsey, S.M.Barnett, M.J.Rohatiner, A.Lister, A.
(2002). Non-myeloablative allografting for patients with myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML).,
BLOOD,
Vol.100
(11),
pp.409A-410A.
Taussig, D.C.Davies, C.Taha, Y.Protheroe, R.Oakervee, H.Davies, A.J.Rohatiner, A.Aitken, C.Cavenagh, J.D.Lister, A.
(2002). Early identification of respiratory virus infection in inpatients with haematological malignancies reduces nosocomial spread.,
BLOOD,
Vol.100
(11),
p.436B.
Pearce, D.Taussig, D.Rohatiner, A.Bonnet, D.
(2002). Comparison of AML engraftment in murine NOD/SCID and beta 2m-/-, NOD/SCID xenotransplantation assays.,
BLOOD,
Vol.100
(11),
p.555A.
Davies, A.J.Micallef, I.N.Taussig, D.C.Cavenagh, J.D.Foran, J.M.McBride, N.Syndercombe-Court, D.Kelsey, S.M.Lister, T.A.Rohatiner, A.Z.
(2000). An open phase II study of non-myeloablative allogeneic stem cell transplantation for refractory/recurrent and poor risk haematological malignancy.,
BLOOD,
Vol.96
(11),
p.353B.
Williams, M.A.Taussig, D.C.Wiggins, C.Feakins, R.M.McBride, N.Newland, A.C.Kelsey, S.M.
(1998). Clinical remission of primary refractory lymphoma following infusion of autologous tumour-peptide charged dendritic cells after myeloablative chemotherapy.,
JOURNAL OF LEUKOCYTE BIOLOGY, ,
p.101.